Template:HSV-1 antiviral treatment - Revision history

Danbot: Convert to AntibioticDose templates for SMW integration

2026-03-20T22:28:36Z

Convert to AntibioticDose templates for SMW integration

← Revisión anterior		Revisión del 22:28 20 mar 2026
Línea 2:		Línea 2:
	====Normal Host====		====Normal Host====
	*Options:		*Options:
	**[[Acyclovir]]		**[[Acyclovir]]
	***400 mg PO 5x/day (q4hrs while awake) x 5 days, OR		***{{AntibioticDose\|drug=Acyclovir\|dose=400 mg PO 5x/day (q4hrs while awake) x 5 days\|context=Normal host\|population=Adult}} OR
	***40-80mg/kg PO divided in 3-4 doses for 5-7 days, OR		***{{AntibioticDose\|drug=Acyclovir\|dose=40-80mg/kg PO divided in 3-4 doses for 5-7 days\|context=Normal host\|population=Pediatric}} OR
	****Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>		***Can also be used as topical cream 5x per day
	**[[Famciclovir]] 500mg PO BID x 7 days, OR		**{{AntibioticDose\|drug=Famciclovir\|dose=500mg PO BID x 7 days\|context=Normal host\|population=Adult}} OR
	**[[Valacyclovir~~]] 2gm~~ PO ~~q12~~ x 1 day		**{{AntibioticDose\|drug=Valacyclovir\|dose=2g PO q12h x 1 day\|context=Normal host\|population=Adult}}

	====Immunocompromised====		====Immunocompromised====
	*Options:		*Options:
	**[[Acyclovir]]		**[[Acyclovir]]
	***5 mg/kg IV ~~(over 1 hours)~~ q8h x 7 days, OR		***{{AntibioticDose\|drug=Acyclovir\|dose=5 mg/kg IV q8h x 7 days\|context=Immunocompromised\|population=Adult}} OR
	***400mg PO 5x/day x 14-21 days		***{{AntibioticDose\|drug=Acyclovir\|dose=400mg PO 5x/day x 14-21 days\|context=Immunocompromised (oral)\|population=Adult}}
	**[[Famciclovir]] 500mg PO BID x 7 days, OR		**{{AntibioticDose\|drug=Famciclovir\|dose=500mg PO BID x 7 days\|context=Immunocompromised\|population=Adult}} OR
	**[[Valacyclovir]] 500mg PO BID x 5-10 days		**{{AntibioticDose\|drug=Valacyclovir\|dose=500mg PO BID x 5-10 days\|context=Immunocompromised\|population=Adult}}

Rossdonaldson1: /* Anti-viral Treatment */

2016-04-26T20:59:38Z

Anti-viral Treatment

← Revisión anterior		Revisión del 20:59 26 abr 2016
Línea 1:		Línea 1:
	===Anti-viral Treatment===		===Anti-viral Treatment===
	~~''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''~~		====Normal Host====

	~~'''~~Normal Host~~'''~~
	*Options:		*Options:
	**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days		**[[Acyclovir]]
	***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>		***400 mg PO 5x/day (q4hrs while awake) x 5 days, OR
	**[[~~Valacyclovir~~]] ~~(significantly higher bioavailability than acyclovir)~~		***40-80mg/kg PO divided in 3-4 doses for 5-7 days, OR
	**[[~~Famciclovir~~]]		****Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>
			**[[Famciclovir]] 500mg PO BID x 7 days, OR
			**[[Valacyclovir]] 2gm PO q12 x 1 day

	~~'''~~Immunocompromised~~'''~~		====Immunocompromised====
	*Options:		*Options:
	**[[Acyclovir]]		**[[Acyclovir]]

Rossdonaldson1: /* Anti-viral Treatment */

2016-04-26T20:56:11Z

Anti-viral Treatment

← Revisión anterior		Revisión del 20:56 26 abr 2016
Línea 1:		Línea 1:
	===Anti-viral Treatment===		===Anti-viral Treatment===
	''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''		''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''
	*~~Antiviral drug options~~:
			'''Normal Host'''
			*Options:
	**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days		**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days
	***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>		***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>
	**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)		**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)
	**[[Famciclovir]]		**[[Famciclovir]]

			'''Immunocompromised'''
			*Options:
			**[[Acyclovir]]
			***5 mg/kg IV (over 1 hours) q8h x 7 days, OR
			***400mg PO 5x/day x 14-21 days
			**[[Famciclovir]] 500mg PO BID x 7 days, OR
			**[[Valacyclovir]] 500mg PO BID x 5-10 days

Rossdonaldson1: /* Anti-viral Treatment */

2016-04-25T21:29:54Z

Anti-viral Treatment

← Revisión anterior		Revisión del 21:29 25 abr 2016
Línea 3:		Línea 3:
	*Antiviral drug options:		*Antiviral drug options:
	**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days		**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days
	***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />		***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan">Mohan RPS, Verma S, Singh U, Agarwal N. Acute primary herpetic gingivostomatitis. BMJ Case Reports. 2013;2013:bcr2013200074. doi:10.1136/bcr-2013-200074.</ref>
	**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)		**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)
	**[[Famciclovir]]		**[[Famciclovir]]

Rossdonaldson1 at 21:28, 25 April 2016

2016-04-25T21:28:53Z

← Revisión anterior		Revisión del 21:28 25 abr 2016
Línea 1:		Línea 1:
			===Anti-viral Treatment===
	''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''		''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''
	*Antiviral drug options:		*Antiviral drug options:

Rossdonaldson1 at 21:27, 25 April 2016

2016-04-25T21:27:13Z

← Revisión anterior		Revisión del 21:27 25 abr 2016
Línea 1:		Línea 1:
	''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''		''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''
	*Antiviral drug		*Antiviral drug options:
	**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days		**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days
	***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />		***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />
	**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)		**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)
	**[[Famciclovir]]		**[[Famciclovir]]

Rossdonaldson1 at 21:26, 25 April 2016

2016-04-25T21:26:40Z

← Revisión anterior		Revisión del 21:26 25 abr 2016
Línea 3:		Línea 3:
	**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days		**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days
	***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />		***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />
	**Valacyclovir (significantly higher bioavailability than acyclovir)		**[[Valacyclovir]] (significantly higher bioavailability than acyclovir)
	**Famciclovir		**[[Famciclovir]]

Rossdonaldson1: Created page with "''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible'' *Antiviral drug **Acyclovir 40-80mg/kg PO divided in 3-4 doses for 5-..."

2016-04-25T21:26:28Z

Created page with "''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible'' *Antiviral drug **Acyclovir 40-80mg/kg PO divided in 3-4 doses for 5-..."

Página nueva

''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible''
*Antiviral drug
**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days
***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" />
**Valacyclovir (significantly higher bioavailability than acyclovir)
**Famciclovir